Clinical significance of connective tissue growth factor (ctgf) and echocardiographic remodeling in patients with ischemic heart disease and chronic heart failure

Authors

  • Tolibjonov Dilmurod Tolibjonovich Assistant, Department of Internal Diseases in Family Medicine No. 1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent, 100109, Uzbekistan Author

Keywords:

ischemic heart disease, chronic heart failure, CTGF, myocardial remodeling, echocardiography, left ventricular ejection fraction

Abstract

Background: Ischemic heart disease (IHD) remains one of the leading causes of chronic heart failure (CHF), morbidity, and mortality worldwide. Progressive myocardial remodeling and fibrosis significantly contribute to left ventricular dysfunction and worsening prognosis in patients with IHD. Connective tissue growth factor (CTGF) has recently emerged as a potential biomarker involved in myocardial fibrosis, extracellular matrix remodeling, and ventricular dysfunction [1,3,5]. Objective: To assess the clinical significance of connective tissue growth factor (CTGF) and echocardiographic remodeling in patients with ischemic heart disease complicated by chronic heart failure. Materials and Methods: A prospective observational study included 67 patients with ischemic heart disease hospitalized in the Cardiology Department of the Multidisciplinary Clinic of Tashkent State Medical University. Clinical, laboratory, and instrumental evaluations were performed in all patients. Serum CTGF levels were assessed, and transthoracic echocardiography was conducted to determine left ventricular ejection fraction (LVEF) and structural remodeling parameters. Patients were stratified according to CTGF levels. Statistical analysis was performed using standard parametric and nonparametric methods, with p < 0.05 considered statistically significant. Results: Elevated CTGF levels were observed in the majority of patients and were associated with reduced left ventricular systolic function and adverse myocardial remodeling. Patients with elevated CTGF demonstrated lower LVEF values ranging between 38–50%, as well as more frequent echocardiographic signs of ventricular remodeling. Increased CTGF concentration was associated with progression of myocardial structural abnormalities and worsening cardiac function.

Conclusion: CTGF may serve as a clinically relevant biomarker reflecting myocardial remodeling and impaired cardiac function in patients with ischemic heart disease and chronic heart failure. Combined assessment of CTGF and echocardiographic parameters may improve risk stratification and optimize personalized therapeutic strategies.

Downloads

Published

2026-06-04

How to Cite

Tolibjonov Dilmurod Tolibjonovich. (2026). Clinical significance of connective tissue growth factor (ctgf) and echocardiographic remodeling in patients with ischemic heart disease and chronic heart failure. UNIVERSAL JOURNAL OF MEDICAL AND NATURAL SCIENCES, 4(36), 237-241. https://sr-journals.org/index.php/UJMANS/article/view/1888